Research Article
Critical Success Factors for Competitive Advantage in Iranian Pharmaceutical Companies: A Comprehensive MCDM Approach
Table 10
The result of MCDA methods.
| ā | ARAS | TOPSIS | VIKOR | MABAC | CoCoSo | WASPAS |
| Firm 1 | 3 | 3 | 2 | 2 | 1 | 3 | Firm 2 | 7 | 7 | 7 | 7 | 5 | 7 | Firm 3 | 8 | 8 | 9 | 8 | 6 | 8 | Firm 4 | 2 | 2 | 4 | 3 | 4 | 2 | Firm 5 | 1 | 1 | 1 | 1 | 3 | 1 | Firm 6 | 5 | 4 | 3 | 5 | 7 | 5 | Firm 7 | 4 | 5 | 5 | 4 | 2 | 4 | Firm 8 | 9 | 9 | 8 | 9 | 9 | 9 | Firm 9 | 10 | 10 | 11 | 10 | 10 | 10 | Firm 10 | 6 | 6 | 6 | 6 | 8 | 6 | Firm 11 | 11 | 11 | 10 | 11 | 11 | 11 |
|
|